BHVN

Biohaven Ltd.
Data: 2026-08-03

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Quick Stats
Aug 03, 2026

51.1

AI Score

HOLD

0.54

Volume Ratio

Aug 10, 2026

Next Earnings

13

+ve Days (30d)

17

-ve Days (30d)

BHVN Stock Summary

Last updated Aug 03, 2026

BHVN is currently trading at $13.37, positioned above its 200-day moving average of $11.56, indicating a long-term uptrend. The stock has a 52-week range of $7.48 to $18.566.

Technical Analysis: The 50-day moving average stands at $13.46, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 43.167, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.026, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates BHVN at 51.1/100 with a HOLD recommendation.

BHVN (Biohaven Ltd.) Indicators

Last updated Aug 03, 2026

Indicator Value
RSI(14) 43.167
CMF (20) -0.026
ROC (10) -10.027
ADX (14) 23.852
Indicator Value
MACD (12,26,9) -0.087
AROONOSC (14) -71.429
WILLAMS %R (14) -90.977
MFI (14) 39.412
BHVN Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

BHVN Price vs Max Options Open Interest
BHVN Max Change In Options Open Interest

BHVN Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BHVN Daily Out of Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BHVN Daily In the Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

BHVN Most Active Options by Volume(near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Biohaven Ltd. is above the 200 Day SMA but below the 50 Day SMA — long-term uptrend intact but under near-term pressure (Mixed).

BHVN Moving Averages Analysis

Biohaven Ltd. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Aug 03, 2026

BHVN (Biohaven Ltd.) Simple Moving Averages

Moving Averages are last updated Aug 03, 2026

Days MA
10 14.16
20 14.78
30 14.99
50 13.46
100 11.46
200 11.56

BHVN Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 2.0 billion
Earnings/Share ($) -5.57
Net Profit Margin (%) --
Dividend/Share ($) --
EPS Estimate Current Year ($) -2.4088
EPS Estimate Next Year ($) -1.944
WallStreet Target Price ($) 22.93
Most Recent Quarter